Christopher O'connor

NPI: 1659455541
Total Payments
$334,635
2024 Payments
$19,431
Companies
13
Transactions
215

Payment Breakdown by Category

Consulting$299,075 (89.4%)
Travel$31,690 (9.5%)
Food & Beverage$3,624 (1.1%)
Other$189.18 (0.1%)
Research$55.67 (0.0%)
Education$2.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $299,075 111 89.4%
Travel and Lodging $31,690 31 9.5%
Food and Beverage $3,624 70 1.1%
Entertainment $189.18 1 0.1%
Unspecified $55.67 1 0.0%
Education $2.00 1 0.0%

Payments by Type

General
$334,580
214 transactions
Research
$55.67
1 transactions

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme LLC $263,341 158 $0 (2024)
E.R. Squibb & Sons, L.L.C. $40,210 21 $0 (2020)
Bayer HealthCare Pharmaceuticals Inc. $23,561 15 $0 (2020)
Actelion Clinical Research, Inc. $5,600 7 $0 (2017)
Regeneron Pharmaceuticals, Inc. $605.00 1 $0 (2022)
Abbott Laboratories $398.90 4 $0 (2019)
Resmed Corp $388.93 3 $0 (2018)
Impulse Dynamics (USA) Inc. $180.54 1 $0 (2023)
CVRx, Inc. $120.00 1 $0 (2023)
ABIOMED $65.06 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $19,431 21 Merck Sharp & Dohme LLC ($19,325)
2023 $10,935 11 Merck Sharp & Dohme LLC ($10,635)
2022 $4,078 7 Merck Sharp & Dohme LLC ($3,473)
2021 $7,475 6 Merck Sharp & Dohme Corporation ($7,475)
2020 $26,145 19 Merck Sharp & Dohme Corporation ($18,100)
2019 $92,431 44 Merck Sharp & Dohme Corporation ($61,198)
2018 $89,736 43 Merck Sharp & Dohme Corporation ($66,741)
2017 $84,403 64 Merck Sharp & Dohme Corporation ($76,394)

All Payment Transactions

215 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/11/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Consulting Fee Cash or cash equivalent $1,300.00 General
Category: CARDIOVASCULAR
11/15/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $315.81 General
Category: CARDIOVASCULAR
11/15/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $254.59 General
Category: CARDIOVASCULAR
11/15/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $219.48 General
Category: CARDIOVASCULAR
11/15/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $125.58 General
Category: CARDIOVASCULAR
11/15/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $51.28 General
Category: Cardiology
10/14/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Consulting Fee Cash or cash equivalent $1,625.00 General
Category: CARDIOVASCULAR
10/02/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Consulting Fee Cash or cash equivalent $1,300.00 General
Category: CARDIOVASCULAR
09/07/2024 AstraZeneca Pharmaceuticals LP WAINUA (Drug) Food and Beverage In-kind items and services $54.09 General
Category: Cardiovascular and Metabolism
08/30/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $120.57 General
Category: CARDIOVASCULAR
08/29/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $9,677.40 General
Category: CARDIOVASCULAR
08/29/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $357.86 General
Category: CARDIOVASCULAR
08/29/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $76.96 General
Category: CARDIOVASCULAR
08/29/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $16.03 General
Category: CARDIOVASCULAR
08/28/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $357.86 General
Category: CARDIOVASCULAR
08/28/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $128.16 General
Category: CARDIOVASCULAR
08/21/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Consulting Fee Cash or cash equivalent $1,625.00 General
Category: CARDIOVASCULAR
08/05/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Consulting Fee Cash or cash equivalent $1,300.00 General
Category: CARDIOVASCULAR
04/05/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $409.80 General
Category: CARDIOVASCULAR
04/05/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $90.04 General
Category: CARDIOVASCULAR
04/05/2024 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $25.00 General
Category: CARDIOVASCULAR
11/29/2023 Merck Sharp & Dohme LLC VERQUVO (Drug) Consulting Fee Cash or cash equivalent $1,625.00 General
Category: CARDIOVASCULAR
11/10/2023 Merck Sharp & Dohme LLC VERQUVO (Drug) Travel and Lodging In-kind items and services $464.30 General
Category: CARDIOVASCULAR
11/10/2023 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $73.24 General
Category: CARDIOVASCULAR
11/10/2023 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $22.40 General
Category: CARDIOVASCULAR

Research Studies & Clinical Trials

Study Name Company Amount Records
Bona-fide Clinical Trial Resmed Corp $55.67 1

About Christopher O'connor

Christopher O'connor is a Cardiovascular Disease healthcare provider based in Falls Church, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659455541.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher O'connor has received a total of $334,635 in payments from pharmaceutical and medical device companies, with $19,431 received in 2024. These payments were reported across 215 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($299,075).

Practice Information

  • Specialty Cardiovascular Disease
  • Other Specialties Cardiovascular Disease
  • Location Falls Church, VA
  • Active Since 10/25/2006
  • Last Updated 02/23/2021
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1659455541

Products in Payments

  • MK-1242 (Drug) $201,820
  • VERQUVO (Drug) $59,009
  • Non-Covered (Drug) $15,250
  • Non-Covered $8,311
  • ApneaLink (Device) $189.18
  • OPTIMIZER (Device) $180.54
  • Xience V coronary stent system (Device) $150.00
  • AirFit (Device) $144.08
  • Absolute Pro vascular stent system (Device) $141.81
  • Barostim Neo System (Device) $120.00
  • Impella (Device) $65.06
  • Resolute (Device) $59.40
  • AirCurve (Device) $55.67
  • No Associated Product (Device) $54.28
  • WAINUA (Drug) $54.09
  • CardioMEMS HF System (Device) $52.81
  • Repatha (Biological) $51.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Falls Church